| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
| Afatinib in Advanced Refractory Urothelial Cancer (NCT02122172) | University of Chicago | 2017-09-13 |
| MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer (NCT02735512) | University of Southern California | 2016-03-01 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer (NCT02316548) | NRG Oncology | 2015-02-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer (NCT01938573) | University of Washington | 2013-10-01 |
| Adjuvant Radiation for High Risk Bladder Cancer (NCT01954173) | Emory University | 2013-07-22 |
| Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521) | University of Southern California | 2013-05-01 |
| Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer (NCT01611662) | Fox Chase Cancer Center | 2012-05-29 |
| Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder (NCT01382706) | University of Southern California | 2011-06-13 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer (NCT01282333) | National Cancer Institute (NCI) | 2011-01-01 |
| Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer (NCT00666562) | National Cancer Institute (NCI) | 2008-07-02 |
| Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361) | M.D. Anderson Cancer Center | 2007-04-01 |
| VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485) | National Cancer Institute (NCI) | 2006-11-01 |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905) | National Cancer Institute (NCI) | 2005-10-01 |
| Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract (NCT00112671) | National Cancer Institute (NCI) | 2005-04-01 |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy (NCT00072137) | National Cancer Institute (NCI) | 2003-10-01 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150) | National Cancer Institute (NCI) | 2003-10-01 |
| Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium (NCT00028756) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-10-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer (NCT00003167) | National Cancer Institute (NCI) | 1998-05-01 |